Cardiovascular Disease and Inflammatory Bowel Disease: Exploring Pathophysiological Links
Investigating the effects of inflammatory burden in inflammatory bowel disease on cardiovascular health sheds light on potential pathophysiological links between the two conditions, informing holistic management strategies and preventive interventions for affected individuals.
December 2020
Maintaining Sexual and Reproductive Health Amidst the Pandemic: A Vital Imperative
Disruption of sexual and reproductive health services during the COVID-19 pandemic poses significant risks, as past epidemics have demonstrated the dire consequences of neglecting essential healthcare services unrelated to epidemic response, underscoring the importance of sustaining comprehensive healthcare provision.
December 2020
Transgender Care: Providing Inclusive and Compassionate Healthcare Services
Comprehensive transgender care requires adherence to general principles of care, evaluation, and treatment, ensuring the provision of inclusive and compassionate healthcare services that meet the unique needs of transgender individuals.
December 2020
Circulation of SARS-CoV-2 in Indoor Environments: Insights from Environmental Monitoring
SARS-CoV-2 RNA levels in indoor air environments are generally undetectable, except in crowded areas, highlighting the importance of infection control measures and ventilation strategies in mitigating viral transmission risks in public settings.
December 2020
Anticoagulants and COVID-19 Survival: Insights from Clinical Studies
Hospitalized COVID-19 patients treated with blood thinners demonstrate improved outcomes, both within and outside the intensive care unit, suggesting a potential survival benefit of anticoagulant therapy in COVID-19 management, warranting further investigation and clinical trials.
December 2020
Temporal Dynamics in Viral Shedding and Transmissibility of COVID-19: Insights from Contact Tracing
Contact tracing data reveal that a significant proportion (44%) of secondary COVID-19 cases are infected during the pre-symptomatic stage of index cases, particularly in settings with family clustering, underscoring the importance of early detection and isolation measures to mitigate transmission risks.
December 2020
Eye Findings of COVID-19 Patients in Hubei Province, China: Insights for Ocular Manifestations
Examination of ocular manifestations in COVID-19 patients from Hubei Province, China, provides valuable data that may aid ophthalmologists and healthcare professionals in understanding the potential involvement of the eyes in the course of the disease.
December 2020
Patients with Serious Mental Illness in the Era of COVID-19: Addressing Vulnerabilities and Treatment Needs
Psychiatrists caring for individuals with serious mental illness must navigate unique challenges and vulnerabilities during the COVID-19 pandemic, requiring tailored interventions and support to meet the complex needs of this patient population amidst the evolving public health crisis.
December 2020
ASA, Clopidogrel, and Prasugrel in Type 2 Diabetes: Thrombotic Marker Effects
A double-blind randomized controlled trial evaluates the effects of ASA, clopidogrel, and prasugrel on thrombotic markers and microRNA levels in patients with type 2 diabetes, providing insights into antiplatelet therapy efficacy and safety profiles in diabetic populations.
December 2020
COVID-19: Kinetics of Viral Clearance and Symptom Resolution
Despite symptom resolution, the virus can remain detectable in patients for up to 8 days after recovery, emphasizing the importance of continued monitoring and infection control measures to prevent transmission during the convalescent period.
December 2020
